OMGA logo

Omega Therapeutics (OMGA)

Profile

Full Name

Omega Therapeutics, Inc.

Ticker Symbol

OMGA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 30, 2021

Indexes

Not included

Website

http://omegatherapeutics.com

Employees

93

Key Details

Price

$0.04(-4.65%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.09M(+49.25% YoY)

Annual EPS

-$1.80(+15.89% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.04
OMGA price is $0.04

30-Day Relative Volume

0.16
OMGA 30-day relative volume is 0.16

Price Performance

Price Most recent change

-4.65%
OMGA price was down -4.65% on Apr 11, 2025

Price YTD change

-94.5%
OMGA price is down -94.5% since January 1st

Price 1-year change

-98.61%
OMGA price is down -98.61% year-on-year

Price 3-year change

-99.32%
OMGA price is down -99.32% over the past 3 years

Price Range

Price All-time high

$31.41
OMGA price is currently -99.87% below its historical high of $31.41

Price 3-year low

$0.01
OMGA price is currently +310.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.27M
OMGA market capitalization is $2.27 million

Market cap 3-year change

-99.22%
OMGA market capitalization is down -99.22% over the past 3 years

Market cap All-time high

$1.40B
OMGA market capitalization is currently -99.84% below its historical high of $1.40 billion

Market cap sector rank

7.23%
OMGA market capitalization is higher than 7.23% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.38%
OMGA shares outstanding is up +0.38% year-on-year

Shares Outstanding 3-Year Change

+15.71%
OMGA shares outstanding is up +15.71% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.05
OMGA beta is -0.05

200-day SMA

$0.94
OMGA price is currently -95.65% below its 200-day simple moving average

50-day SMA

$0.09
OMGA price is currently -55.04% below its 50-day simple moving average

RSI

43.18
OMGA 14-day relative strength index is 43.18

Volume

0.16
OMGA 30-day relative volume is 0.16

ATR

$0.03
OMGA average true range is $0.03

10-day Historical Volatility

566.48%
OMGA 10-day historical volatility is 566.48%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.09M
OMGA annual revenue is $3.09 million

Revenue Analysts estimate

$6.19M
OMGA annual revenue is currently -50.05% lower than the consensus analysts' forecast

Revenue 1-year change

+49.25%
OMGA annual revenue is up +49.25% year-on-year

Revenue Sector rank

18.37%
OMGA annual revenue is higher than 18.37% of companies in Healthcare sector

EPS

EPS

-$1.80
OMGA annual earnings per share is -$1.80

EPS Analysts estimate

-$1.23
OMGA annual earnings per share is currently +46.34% higher than the consensus analysts' forecast

EPS 1-year change

+15.89%
OMGA annual earnings per share is up +15.89% year-on-year

EPS Sector rank

40.63%
OMGA annual earnings per share is higher than 40.63% of companies in Healthcare sector

Profit

Gross profit

-
OMGA annual gross profit value is unknown

Gross margin

-
OMGA annual gross profit margin value is unknown

Operating profit

-$100.26M
OMGA annual operating income is -$100.26 million

Operating margin

-3240.50%
OMGA annual operating profit margin is -3240.50%

Net income

-$97.43M
OMGA annual net profit is -$97.43 million

Net margin

-3148.93%
OMGA annual net profit margin is -3148.93%

Expenses

Total expenses

$103.36M
OMGA annual total expenses is $103.36 million

Operating expenses

$103.36M
OMGA annual total operating expenses is $103.36 million

Cost of goods sold

-
OMGA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$26.19M
OMGA annual SGA is $26.19 million

Depreciation and amortization

$6.77M
OMGA annual depreciation & amortization is $6.77 million

Interest expense

-
OMGA annual interest expense value is unknown

Income tax

-
OMGA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$100.26M
OMGA annual earnings before interest & taxes is -$100.26 million

EBITDA

-$93.49M
OMGA annual EBITDA is -$93.49 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$204.37M
OMGA annual total assets is $204.37 million

Non current assets

$114.48M
OMGA annual long term assets is $114.48 million

Current assets

$89.88M
OMGA annual total current assets is $89.88 million

Cash and cash equivalents

$68.44M
OMGA annual cash & cash equivalents is $68.44 million

Accounts receivable

$5.13M
OMGA annual accounts receivable is $5.13 million

Inventory

-
OMGA annual inventory value is unknown

Liabilities

Total liabilities

$146.35M
OMGA annual total liabilities is $146.35 million

Long term liabilities

$119.54M
OMGA annual total long term liabilities is $119.54 million

Current liabilities

$26.81M
OMGA annual total current liabilities is $26.81 million

Accounts payable

$1.62M
OMGA annual accounts payable is $1.62 million

Debt

Total debt

$128.43M
OMGA annual total debt is $128.43 million

Total debt 1-year change

+468.77%
OMGA annual total debt is up +468.77% year-on-year

Long term debt

$113.13M
OMGA annual long term debt is $113.13 million

Short term debt

$15.30M
OMGA annual short term debt is $15.30 million

Equity & Capital

Shareholders equity

$58.02M
OMGA annual stockholders equity is $58.02 million

Book value

$58.02M
OMGA annual book value is $58.02 million

Retained earnings

-$334.63M
OMGA annual retained earnings is -$334.63 million

Working capital

$63.08M
OMGA annual working capital is $63.08 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$91.51M
OMGA annual cash flow from operations is -$91.51 million

Cash from operations 1-year change

+7.11%
OMGA annual cash flow from operations is up +7.11% year-on-year

Cash from investing

$47.52M
OMGA annual cash flow from investing activities is $47.52 million

Cash from investing 1-year change

+363.1%
OMGA annual cash flow from investing activities is up +363.1% year-on-year

Cash from financing

$41.82M
OMGA annual cash flow from financing activities is $41.82 million

Cash from financing 1-year change

+5807.2%
OMGA annual cash flow from financing activities is up +5807.2% year-on-year

CAPEX

CAPEX

$2.87M
OMGA annual capital expenditures is $2.87 million

CAPEX 1-year change

+107.9%
OMGA annual capital expenditures is up +107.9% year-on-year

Free Cash Flow

Free cash flow

-$94.38M
OMGA annual free cash flow is -$94.38 million

Free cash flow 1-year change

+5.52%
OMGA annual free cash flow is up +5.52% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
OMGA annual gross profit margin value is unknown

Operating margin

-3240.50%
OMGA annual operating profit margin is -3240.50%

Net margin

-3148.93%
OMGA annual net profit margin is -3148.93%

ROA & ROE

ROA

-55.62%
OMGA annual return on assets is -55.62%

ROE

-118.82%
OMGA annual return on equity is -118.82%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
OMGA price to earnings ratio value is unknown

PE ratio Sector rank

-
OMGA price to earnings ratio is unknown

PB Ratio

PB ratio

0.20
OMGA price to book ratio is 0.20

PB ratio Sector rank

19.57%
OMGA price to book ratio is higher than 19.57% of companies in Healthcare sector

PS Ratio

PS ratio

0.28
OMGA price to sales ratio is 0.28

PS ratio Sector rank

9.74%
OMGA price to sales ratio is higher than 9.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$100.03M
OMGA enterprise value is $100.03 million

Enterprise value Sector rank

50.7%
OMGA enterprise value is higher than 50.7% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.50
OMGA EV/EBITDA is -1.50

EV/EBITDA Sector rank

36.4%
OMGA EV/EBITDA is higher than 36.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.35
OMGA annual current ratio is 3.35

Quick ratio

-
OMGA annual quick ratio value is unknown

Leverage

Debt to equity

0.33
OMGA annual debt to equity ratio is 0.33

Interest coverage ratio

-
OMGA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
OMGA piotroski f-score value is unknown

Altman Z-Score

-3.52
OMGA altman z-score is -3.52

Analyst ratings

Recent major analysts updates

Nov 15, 24 Piper Sandler
Overweight
Aug 15, 24 HC Wainwright & Co.
Buy
Aug 7, 24 Wedbush
Outperform
Aug 7, 24 Chardan Capital
Buy
Jun 18, 24 Raymond James
Outperform
May 13, 24 HC Wainwright & Co.
Buy
May 7, 24 Chardan Capital
Buy
Apr 30, 24 HC Wainwright & Co.
Buy
Apr 3, 24 Piper Sandler
Overweight
Apr 1, 24 Chardan Capital
Buy

Institutional Ownership

Similar stocks

PTIX logo
Protagenic Therapeutics (PTIX)
SQL logo
SeqLL (SQL)
QLGN logo
Qualigen Therapeutics (QLGN)
Syra Health Corp Class A (SYRA)
GCTK logo
GlucoTrack (GCTK)
ENVB logo
Enveric Biosciences (ENVB)
CERO logo
CERo Therapeutics Holdings (CERO)
BBLG logo
Bone Biologics (BBLG)
THAR logo
Tharimmune (THAR)
  • What is the ticker symbol for Omega Therapeutics?
  • Does Omega Therapeutics pay dividends?
  • What sector is Omega Therapeutics in?
  • What industry is Omega Therapeutics in?
  • What country is Omega Therapeutics based in?
  • When did Omega Therapeutics go public?
  • Is Omega Therapeutics in the S&P 500?
  • Is Omega Therapeutics in the NASDAQ 100?
  • Is Omega Therapeutics in the Dow Jones?
  • When was Omega Therapeutics's last earnings report?
  • When does Omega Therapeutics report earnings?
  • Should I buy Omega Therapeutics stock now?

What is the ticker symbol for Omega Therapeutics?

The ticker symbol for Omega Therapeutics is NASDAQ:OMGA

Does Omega Therapeutics pay dividends?

No, Omega Therapeutics does not pay dividends

What sector is Omega Therapeutics in?

Omega Therapeutics is in the Healthcare sector

What industry is Omega Therapeutics in?

Omega Therapeutics is in the Biotechnology industry

What country is Omega Therapeutics based in?

Omega Therapeutics is headquartered in United States

When did Omega Therapeutics go public?

Omega Therapeutics's initial public offering (IPO) was on July 30, 2021

Is Omega Therapeutics in the S&P 500?

No, Omega Therapeutics is not included in the S&P 500 index

Is Omega Therapeutics in the NASDAQ 100?

No, Omega Therapeutics is not included in the NASDAQ 100 index

Is Omega Therapeutics in the Dow Jones?

No, Omega Therapeutics is not included in the Dow Jones index

When was Omega Therapeutics's last earnings report?

Omega Therapeutics's most recent earnings report was on Mar 28, 2025

When does Omega Therapeutics report earnings?

The date for Omega Therapeutics's next earnings report has not been announced yet

Should I buy Omega Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page